Drug details
Lyumjev (insulin lispro-aabc injection)
type of Antidiabetics, Insulins, Antidiabetics, Rapid-Acting Insulins
Lyumjev (insulin lispro-aabc) is a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
This drug may have the following side effects:
- confusion,
- dizziness,
- diarrhea
- headache,
- sweating,
- poor coordination,
- vomiting, and
- irritability,
- hunger,
- rapid heartbeats,
- coma,
- shakiness,
- convulsions (seizures)
- moodiness or sudden changes in behavior,
- fainting and unconsciousness,
The following drugs are related to Lyumjev, either as a replacement or used together:
- Actoplus MET, Actoplus MET XR (pioglitazone hcl and metformin hcl)
- Kazano (alogliptin and metformin hcl tablets)
- Apidra (insulin glulisine [rdna origin] inj)
- Avandamet (rosiglitazone maleate and metformin hcl)
- Invokamet XR (canagliflozin and metformin hydrochloride)
- Invokamet (canagliflozin and metformin hydrochloride tablets)
- Xigduo XR (dapagliflozin and metformin hcl extended-release tablets)
- Lantidra (donislecel-jujn allogeneic pancreatic islet cellular)
- Synjardy XR Extended-release Tablets (empagliflozin and metformin hydrochloride extended-release)
- Synjardy (empagliflozin and metformin hydrochloride tablets)
- Fiasp (insulin aspart injection for subcutaneous or intravenous use)
- Glucovance (glyburide and metformin)
- Humalog (insulin lispro (human analog))
- Humalog 75-25 (75-25 insulin lispro suspension and 25 insulin lispro injection)
- Humalog Mix 50-50 (insulin lispro)
- Tresiba (insulin degludec injection)
- Levemir (insulin detemir)
- Lantus (insulin glargine [rdna origin] injection)
- Toujeo (insulin glargine injection for subcutaneous use)
- Janumet (sitagliptin metformin hcl)
- Janumet XR (sitagliptin and metformin hcl)
- Jentadueto (linagliptin and metformin hydrochloride)
- Jentadueto XR (linagliptin and metformin hydrochloride extended-release tablets)
- Kombiglyze XR (saxagliptin and metformin hcl extended-release)
- Prandimet (repaglinide and metformin hcl tablets)
- Tzield (teplizumab-mzwv injection, for intravenous use)